Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

US Patent 11020492 · Granted Jun 1, 2021

Estimated economic value: $30,759,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Controlled transgene expression in regulatory t cells2025
Catheter in bag without additional packaging2025
Device for controlling fecal incontinence2025
Methods and compositions for modification of a cystic fibrosis transmembrane con2024
Device for controlling fecal incontinence2023
Catheter in bag without additional packaging2023
Delivery of target specific nucleases2023
Genetic modification of cytokine inducible SH2-containing protein (CISH) gene2023
Methods and compositions for modification of a cystic fibrosis transmembrane con2023
Catheter grip and method2023
Targeted disruption of T cell and/or HLA receptors2022
Device for controlling fecal incontinence2021